EC Number   |
Title |
Organism |
|---|
   3.4.24.56 | Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice |
Mus musculus |
| 3.4.24.56 | Characteristics of insulin-degrading enzyme in Alzheimers Disease a meta-analysis |
Homo sapiens |
| 3.4.24.56 | Characterization of a species-specific insulinase-like protease in Cryptosporidium parvum |
Cryptosporidium parvum |
| 3.4.24.56 | Characterization of insulin-degrading enzyme-mediated cleavage of Abeta in distinct aggregation states |
Homo sapiens |
| 3.4.24.56 | Dual exosite-binding inhibitors of insulin-degrading enzyme challenge its role as the primary mediator of insulin clearance in vivo |
Homo sapiens |
| 3.4.24.56 | Dual exosite-binding inhibitors of insulin-degrading enzyme challenge its role as the primary mediator of insulin clearance in vivo |
Mus musculus |
| 3.4.24.56 | Enzyme kinetics from circular dichroism of insulin reveals mechanistic insights into the regulation of insulin-degrading enzyme |
Homo sapiens |
| 3.4.24.56 | Functional requirement for human pitrilysin metallopeptidase 1 arginine 183, mutated in amyloidogenic neuropathy |
Homo sapiens |
| 3.4.24.56 | Inhibition of insulin-degrading enzyme does not increase islet amyloid deposition in vitro |
Mus musculus |
| 3.4.24.56 | Inositol phosphates and phosphoinositides activate insulin-degrading enzyme, while phosphoinositides also mediate binding to endosomes |
Rattus norvegicus |
